Skip to main content

Preprocedural fasting for contrast-enhanced CT: when experience meets evidence


Traditional preparatory fasting policy prior to iodinated contrast media (ICM) assisted contrast-enhanced CT (CECT) examinations lacks methodologically acceptable evidence. Considering the possible negative effects of preprocedural fasting, the latest European Society of Urogenital Radiology guidelines V10.0 and American Committee of Radiology 2021 guidelines clearly state that preprocedural fasting is not recommended prior to routine intravenous ICM administration. This comprehensive and detailed Review presents the current global dietary preparation policies, potential harm of excessive fasting, and a systematical and well-bedded description of practice advancements of dietary preparation. The evidences revealed that there has been no single instance of vomiting-associated aspiration pneumonia due to the undemanding implementation of preparatory fasting prior to CECT yet. Non-fasting would not increase the incidence of emetic symptoms and the risk of aspiration pneumonia. Not every patient should undergo all CECT examinations without preparatory fasting. There is still much more refinement to be done on the preparatory fasting policy. Changes in traditional preparatory fasting policy will make positive and significant implications on clinical practice. This Review aims to provide operational guidance and suggestions for practitioners and policymakers, motivate efficient, reasonable, safe and normative ICM usage, and achieve optimal patient clinical benefits and high-quality radiological care practices.

Key points

  • Traditional preparatory fasting policy prior to CECT lacks methodologically acceptable evidence.

  • Excessive fasting may bring a series of negative effects on patients.

  • Non-fasting will not increase the risk of aspiration pneumonia and the incidence of emetic complications.

  • Not every patient should undergo all CECT examinations without preparatory fasting.

  • Changes in current preparatory fasting policy will make significant implications on clinical practice.


With the increased availability of CT imaging equipment and rapid advancements of contrast enhancement technology, iodinated contrast media (ICM) assisted contrast-enhanced CT (CECT) examination has become one of the most dominating diagnostic procedures in radiology departments worldwide. CECT increases the image contrast and diagnostic information, and improves the detection rate of lesions, especially tiny or small lesions. According to the different enhancement patterns and degrees of different lesions, CECT is helpful to the diagnosis and differential diagnosis, and shows great clinical application value [1]. As a time-honored tradition, patients are typically instructed to fast for 4–6 h prior to CECT in the majority of medical institutions throughout the world [2]. Preoperative fasting is defined as a prescribed period of time before a procedure when patients are allowed eating and drinking nothing by mouth [3]. The original intention was to prevent emetic complications (e.g., nausea and vomiting) and possible aspiration after ICM administration. Historically, Mendelson reported preoperative fasting in obstetric patients receiving general anesthesia in 1946 [4], and first introduced the concept of pulmonary acid aspiration syndrome, which indicated inhalation of gastric fluid contents induced lung damage. Preoperative fasting was thought to reduce the risk and severity of regurgitation of gastric contents and pulmonary acid aspiration syndrome during anesthesia, although the latter was extremely rare and often non-fatal [5]. For the next 70 years, this preparatory fasting regimen has been gradually promoted as a routine preparation protocol, which is regularly applied in various diagnostic and therapeutic procedures that require general anesthesia, local anesthesia, procedural sedation and analgesia, and even prior to CECT which require intravenous injection of ICM. According to the updated American Society of Anesthesiologists (ASA) 2017 guidelines, patients should fast for 2 h, 6 h, and 8 h from clear fluids, light meal and high-fat solids prior to general anesthesia to prevent possible aspiration pneumonia [6]. Very recently, using evidence-based factors and a consensus-derived algorithm, graded fasting precautions for liquids and solids are recommended for elective procedural sedation by International Committee for the Advancement of Procedural Sedation [7].

The initial driving factor of preparatory fasting orders prior to CECT was prompted on a logical assumption that practitioners and policymakers believed that vomiting is more likely to occur when the stomach cavity is full [8]. Fasting is to accelerate gastric emptying as much as possible, and to prevent aspiration of gastric contents and subsequent aspiration pneumonia when patients receive high-osmolality contrast media (HOCM) in a supine position. In the era of first-generation ionic HOCM, the frequency of nausea and vomiting was up to 4.58% and 1.84%, respectively [9]. On the other hand, once severe life-threatening events occur, empty stomach and unobstructed airway can contribute to the convenient implementation of emergency tracheal intubation and airway manipulation. Given this, it seemed necessary, reasonable, and meaningful to conduct preparatory fasting in the past. Despite the fact that there is substantially minimal conclusive and direct scientific evidence to support this practice, and current preparatory fasting policies regarding content and duration prior to CECT lack standardization and are highly heterogeneous across medical institutions and countries (ranging from no fasting to overnight fasting), preparatory fasting remains a universal and common request worldwide [2, 10].

With the introduction and extensive applications of nonionic ICM, ionic HOCM has been gradually phased out from the market. Nowadays, almost all industrialized countries only use nonionic low-osmolality contrast media (LOCM) and iso-osmolality contrast media (IOCM). The classification and physicochemical properties of ICM are shown in Table 1. The manufacturers of nonionic ICM declare that, except for adequate hydration, no other special preparation procedures are required prior to CECT. Nonionic ICM has been shown to reduce the frequency of nausea and vomiting to 0.013% and 0.059% respectively [11]. The literature estimates of the incidence of emetic symptoms are shown in Table 2. Up to now, no case of aspiration pneumonia has been identified due to the undemanding compliance with preparatory fasting prior to CECT yet. Therefore, current overfocus on preparatory fasting may be probably misguided, which may only give practitioners and policymakers false sense of security when holding fasting orders. Its necessity and rationality are increasingly concerned and questioned by clinical departments and radiology departments. It would not seem prudent to fast without distinction for every patient without evidence-based considerations. It is important to note that preparatory fasting has known negative effects on patients, including, but are not limited to, general discomfort (e.g., irritability, dehydration), and hypoglycemic risk in diabetic patients. The latest European Society of Urogenital Radiology (ESUR) guidelines and American Committee of Radiology (ACR) guidelines clearly state that fasting is not recommended prior to routine intravenous ICM administration [33, 34]. In other words, the most frequent dietary protocols, sometime considered a "mandatory preparation regimen", are arbitrary and unjustified, and the existing fasting strategies can reasonably be less restrictive. Nevertheless, as currently practiced, some institutions appear to be reluctant to "deviate from the fasting dogma", attributed to their reliance on deep-rooted clinical experience patterns and lack of evidence-based knowledge.

Table 1 Classification and physicochemical characteristics of ICM
Table 2 Literature estimates of the incidence of nausea and vomiting symptoms in CECT examinations

This panoramic Review starts with an overview of emetic and aspiration symptoms. It then presents the current status of global dietary preparation policies prior to CECT and potential harm of excessive fasting, with a comprehensive and detailed description of the state-of-the-art clinical practice advancements of dietary preparedness. Finally, it discusses the existing issues and prospects possible future striving directions. This review aims to deepen the understanding of the dietary preparedness prior to CECT, provide operational guidance and suggestions for practitioners and policymakers, motivate efficient, reasonable, safe and normative ICM usage, and achieve optimal patient clinical benefits and high-quality radiological care practices (Fig. 1).

Fig. 1
figure 1

The negative effects of excessive preprocedural fasting and the benefits of non-fasting prior to CECT

Possible predisposing factors for emetic symptoms

Nausea and vomiting are collectively known as emetic complications. There are a variety of possible predisposing factors for nausea and vomiting occurrence [35], include, but are not limited to: (i) Mental factors: Some patients are extremely anxious, nervous, and even scared about their own conditions. In this scenario, vomiting is easy to occur prior to CECT. (ii) Pharmacological effects: Patients receiving rapid intravenous ICM administration may experience transient oral metal odor, which usually lasts for 10–15 s and then disappears naturally. Patients who are sensitive to peculiar smells may develop transient nausea and vomiting. This is more frequent in HOCM, and most symptoms undergo spontaneous remission without treatment. (iii) Primary diseases: for patients suffering from digestive system infectious diseases, visceral pain diseases, central nervous system diseases, neurogenic vomiting, hypoglycemia, and patients who are under chemotherapy [36, 37], vomiting symptoms may appear or intensify after ICM administration. (iv) Other factors: The causal factors and severity of vomiting is related to overeating or drinking liquids (e.g., sour milk and soda beverages) that produce acid and gas.

It is worth noting that emetic symptoms are often infrequent, transient and self-limited, and vomiting does not necessarily mean pulmonary aspiration, which is defined as inhalation of oropharyngeal or gastric contents into the larynx and lower respiratory tract [38]. Whether in theory or practice, aspiration is more likely to appear in patients with dangerous status such as impaired consciousness, increased intracranial pressure, posterior cranial nerve injury, weakened swallowing reflex, and tracheal intubation. For conscious and cooperative patients, aspiration can be readily avoided simple motions such as turning the head, vomiting, and swallowing. Undoubtedly, the outcome and related risks of aspiration in fully conscious patients during CECT are almost certainly low than those under general anesthesia. It is generally accepted that at least 25 mL (pH = 2.5, > 0.4 mL kg−1) of liquid aspiration are required to induce clinically significant lung damage [39]. The volume of gastric contents and the pH of gastric cavity are key factors that affect the consequences of aspiration [40]. Studies showed that prolonging the fasting duration prior to CECT could increase the incidence and severity of emetic complications [12]. Note that fasting does not guarantee an empty stomach. Fasting for more than 3 h not only could not further reduce the volume of stomach contents, but also could lower the pH of gastric cavity [41]. This would increase the risk of aspiration pneumonia. For patients who developed aspiration, the consequences might be more severe.

Current status of global dietary preparation policies prior to CECT

Lee et al. conducted a multinational survey on the time interval of preparative fasting protocols prior to elective non-gastrointestinal CECT, obtaining responses from 69 institutions in 6 countries [2]. The results showed that the fasting policies highly heterogeneous among different countries, and even among different institutions in any same country, ranging from no fasting to overnight fasting. The fasting duration for solids in the United States, Korea, and Egypt were 0–6 h, 0–8 h, and 0 h-overnight, respectively, and the fasting duration for liquids were 0–4 h, 0–8 h, and 0–6 h in these three countries, respectively [2]. Of the 49 hospitals that implemented solids fasting, the fasting duration for solids were longer than liquids in 20 hospitals [2]. In another multinational survey investigation by Han et al. [10], among 58 Korean hospitals surveyed, 57 instructed patients to fast, of which 33 instructed fasting from both solids and water, with a median fasting time of 6 h. Among 15 Korean hospitals surveyed, 12 instructed patients to fast, of which 10 instructed fasting from only solids, with a median fasting time of 4 h [10].

ESUR Guidelines V10.0 in 2018 stated that fasting was not recommended prior to injection of nonionic LOCM or IOCM [33]. Very recently, ACR 2021 guidelines deliberately added a new chapter for the fasting policy prior to intravenous ICM injection [34]. It recommended that fasting was not required prior to routine intravascular injection of ICM. However, for patients who receiving sedation and anesthesia, the American Society of Anesthesiology guidelines should be consulted [42]. In China, according to the Practice of Medical Imaging Technology Guidelines, the fasting duration for patients receiving non-gastrointestinal examinations and gastrointestinal examinations were 4 h and 4–8 h, respectively [43]. As currently practiced, water can serve as a negative oral contrast agent for gastrointestinal examinations [44, 45]. CT examination technology expert consensus recommended that fasting for at least 4 h was required for gastric enhancement scan [1], and about 800–1000 mL water intake was encouraged prior to gastric and small intestinal examinations. The purpose was to ensure good filling of gastrointestinal tract, to provide universally recognized quality images, and to avoid misdiagnosis and missed diagnosis [46]. Furthermore, patients are strongly encouraged to ingest fluid intravenously or orally (called hydration) hour after hour from 6 to 12 h prior to CECT and within 24 h after examinations [47], to prevent possible contrast-induced nephropathy in high-risk patients [48]. However, for outpatients and emergency patients, intravenous hydration is impractical and oral hydration is more easily available, making the preparatory fasting policy contradictory.

The potential harm of excessive fasting

The types and contents of solids and liquids consumed must be taken into consideration when determining an appropriate fasting duration. Evidences on gastric emptying investigations showed that clear liquids containing particles smaller than 2 mm were emptied in an exponential manner, with 10–20 min for 50% emptying, 1 h for 90% emptying, and 2 h for almost complete emptying, respectively [40]. The overall gastric emptying rate of milk in infants and children under 5 years of age is ≥ 80% within 3 h [49]. The emptying rate of solids varies greatly, with 5 h for 50% emptying and about 12 h for complete emptying, respectively. Consuming fatty or fried foods or meat may lead to prolonged time for the stomach to empty. Patients with weakened bowel movement or damaged gastrointestinal function require longer empty time [3].

Although we have obtained the approximate stomach emptying time for different foods, and have recognized the ineffectiveness of traditional fasting regimens [50, 51], some difficulties remain in implementing the new dietary preparation instructions in clinical practice, such as unnecessary fasting or excessive fasting. The reality is that practitioners and policymakers are reluctant to "break the fasting dogma", attributed to their reliance on deep-rooted clinical experience patterns. Some of them even mistakenly believe that the longer the fasting period, the safer the patient. If they deviate from existing guidelines, they are likely to be challenged and face with criticism. In many medical institutions, to avoid risks and responsibilities, many inpatients are near-universally asked to fast substantially exceeding the recommended fasting thresholds by guidelines [52], because they are usually scheduled for multiple radiology and laboratory examinations on the same day. If a patient is scheduled for CECT in the next morning, it has become time-honored tradition to restrict the consumption of liquids and solids from after dinner the day before. This extreme practice may seem to increase the scheduling flexibility of the radiology department on the next day. However, for individual patients, the experience and comfort are greatly reduced, and a series of additional harm are likely to occur.

Excessive fasting can increase the patients’ stress responses into a catabolic state, disrupt the body's internal environment and metabolic balance, and increase the risk of ADR after ICM injection [53,54,55]. Patients are more susceptible to irritability and anxiety during the waiting or examination process, presented as poor compliance and noncooperation. For elderly patients with malnutrition and weak constitution, they are particularly vulnerable to physical discomfort (e.g., palpitation, thirst, hunger, exhaustion), muscle weakness, hypoglycemia, hypotension, and dehydration symptoms [51, 56,57,58]. In addition, patients usually choose to stop routine medications during fasting period, which may aggrandize the health risks for patients with diabetes, hypertension, and those who need continuous medication. For patients with special needs, such as diabetic patients, strict fasting from liquids and solids is difficult [51]. For infants and children, excessive fasting can adversely affect metabolism and behaviors [40, 59, 60], leading to irritability and noncooperation [61], particularly susceptible to dehydration and hypoglycemia [62]. This would increase the risk of emetic symptoms [63]. Therefore, these patients will not benefit from any period of fasting. Withholding unreasonable fasting orders and improving patients’ cognitive ability of dietary preparation may increase patient benefits, manage patient turnaround time in the radiology department more effectively. This is significant to save medical resource costs and improve the quality of the radiological care practice.

Practice progresses of dietary preparation prior to CECT

Given doubts about the necessity and rationality on preparatory fasting, some preliminary attempts and explorations have been made. Very early, Wagner et al. first reported no statistical difference in the frequency of emetic complications between patients who did not fast and those who fasted for at least 4 h [64]. Similarly, Park et al. observed 122 adult patients undergoing abdominal CT examinations due to acute abdominal pain, and found no significant difference in the frequency of emetic complications between patients who did not fast and those who fasted for more than 6 h [65]. In another study by Oowaki et al. [12], preparatory fasting could increase the incidence of emetic complications for HOCM, while not for LOCM. Emetic complications were more frequent in patients who fasted for a prolonged time. In 2012, Lee et al. conducted a rigorous systematic review of 13 studies through Medline [2]. No aspiration was identified in any of 2001 patients who ingested clear inert liquids within 1 h prior to CECT, indicating that fluids ingestion should not be restricted.

In our own practice, since June 2015, we have abolished traditional fasting instructions prior to routine CECT examinations in our institution. Unless compulsory for clinical treatment needs and gastrointestinal examinations, liquids and solids are not restricted in other routine examinations. For urgent or emergency CECT examinations, no delay is based on fasting time. During the next 7 years, more than 450,000 cases of CECT examinations have been performed. Neither increased incidence of emetic complications no case of aspiration pneumonia was observed [11, 29, 66]. These interesting findings suggest that withholding fasting orders does not offer any additional harm for patients, which should be verified in longer observation period and more other institutions. Very recently, a variety of clinical investigations such as prospective clinical observations, retrospective analysis, historical controlled trials, and prospective randomized controlled trials, have been reported, which provided valuable clinical references for reevaluating current preparatory fasting policy (Table 3). These studies attempt to answer five specific questions that need to be addressed: (i) Must all patients fast? (ii) Which population need to fast? (iii) What is the most appropriate fasting duration? (iv) What is the specific fasting content? (v) What harm may occur after fasting?

Table 3 Examples of preparative fasting policies prior to CECT in literature

Prospective clinical observations

Li et al. first conducted a prospective observation in a large-scale population who underwent routine CECT [11]. Among them, 51,807 cases fasted from solids for 4 h, and 59,029 cases were not restricted from solids, and free liquids consumption was allowed for all patients. The results showed an extremely low total incidence of emetic complications (0.071%), and no case of aspiration was identified. Such a low incidence was attributed to the standardized pre-inspection screening and evaluation process implemented by the author's institution. There was no statistical difference in the frequency of emetic complications between the two groups of patients with different basic data. The patients with an ICM-ADR history (1.04%) had a higher incidence of emetic complications than those with other ADR histories (0.12%) and those without ADR history (0.06%). They concluded that there was no association between the solid preparedness and the occurrence of emetic complications. Patients with an ICM-ADR history should be given particular attention to reduce possible adverse events.

In another study, Kim et al. evaluated the effect of fasting duration on the occurrence of emetic complications in 1175 adult patients [31]. The patients received instructions for preparatory fasting for 6 h from solids. As a result, 34 cases (2.9%) developed mild nausea after receiving LOCM and no case of vomiting was identified. The actual median fasting duration for solids and liquids were 14 h and 11 h, respectively. The length of fasting time from solids and liquids were not related to the nausea severity, indicating that a considerable proportion of patients experienced unnecessary excessive fasting longer than the instructed interval. Furthermore, they identified that drug allergy history (excluding ICM hypersensitivity) and iobitridol usage were independent risk and protective factors for nausea respectively, with an odds ratio of 4.33 and 0.32, respectively.

Retrospective analysis on pediatric patients

Infants and children have high nutritional requirements, strong metabolism, and low glycogen storage, representing a special patient population that requires special attention. Excessive fasting can detrimentally affect their metabolism and behaviors [40, 59, 60, 62], leading to irritability, noncooperation, and especially prone to dehydration and hypoglycemia. Currently, the vast majority of studies involving preprocedural fasting in children focus on the fields of surgery and anesthesia, and preparatory fasting prior to radiological procedures mostly follows the fasting schemes adopted in these fields [70]. Sedation is often required for some children to control their behaviors and movement, to ensure the high quality of the scanned images. According to the latest anesthesia guidelines, for infants and children who require sedation, clear fluids, breast milk, and solids should be restricted for 2 h, 4 h, and 6 h, respectively (named 6–4–2 fasting regimen) [60, 63, 70]. There are no standard preparatory fasting recommendations for children who do not require sedation yet.

Ha et al. evaluated the incidence of emetic complications and their risk factors after intravenous LOCM administration in pediatric patients [32]. For patients who required oral sedation or who did not require sedation, the fasting duration from solids and non-clear liquids depended on their ages. The fasting duration in infants under 12 months, children that were 1–4 years old, and children that were 5–20 years old were 2 h, 3 h, and 4 h, respectively, without restriction on clear liquids ingestion (e.g., water and tea without carbohydrates). For patients who require intravenous sedation, the aforementioned 6–4–2 fasting regimen was implemented regardless of their ages. The results showed that of the evaluated 864 patients, 18 cases (2.1%) developed emetic complications, with a low incidence of severe vomiting (0.22%), and no case of aspiration pneumonia was identified. 57.2% of patients experienced unnecessary excessive fasting. The average fasting duration in patients with and without emetic complications were 7.9 h and 8.7 h, respectively, indicating no correlation between fasting time interval and the occurrence of emetic complications. Further analysis showed that ongoing chemotherapy, iomeprol, and iohexol usage were independent risk factors, with odds ratios of 4.323, 7.219, and 5.241, respectively.

Historical control trials

The ESUR guideline version 10.0 released in 2018 clearly states that preparatory fasting is not recommended prior to nonionic LOCM or IOCM administration [33]. To follow this new statement, Tsushima et al. abolished the traditional one-meal fasting policy, announcing in-house that solids were no longer forbidden prior to CECT [68]. The effect of policy changes on the incidence of acute ADR was analyzed. The results showed no significant difference in the overall frequency of acute ADR (1.6% vs 1.4%) and severe allergy-like reactions (0.06% vs 0.05%) before and after the policy change (1.4%). After abolishing the fasting instructions, the incidence of nausea (0.18% vs 0.31%) and vomiting (0.16% vs 0.12%) decreased significantly and remained unchanged respectively, and no case of aspiration pneumonia was identified. Considering that the decreased frequency of nausea may decline patient discomfort, the historical control results suggested that there was no need for preparatory fasting prior to CECT.

Prospective randomized controlled trials

CECT is indispensable significance for rational tumor theranostics, including preoperative diagnosis and staging, formulation of treatment plans, evaluation of treatment responses, and follow-up review. Tumor patients are often accompanied with other major chronic diseases due to their poor physical conditions. The long-term radiotherapy and the radiation superposition effect of multiple CECT scans contributed to increased ADR risk following ICM administration. In addition, some anti-tumor drugs can induce hypersensitivity, which may further aggravate the susceptibility and severity of allergic-like reactions. Barbosa et al. first reported a prospective randomized clinical trial based on 3206 adult outpatients at a cancer center [67]. The fasting group fasted for at least 4 h, and 1.5% of patients developed ADR. In the non-fasting group, with a light meal (e.g., juice, jelly, biscuits and sandwiches) within 1 h prior to examination, 0.9% of patients developed ADR. There was no significant difference in the frequency of symptoms between the two groups. The most common manifestations were nausea, weakness, and vomiting. In addition, although not common, some unexpected symptoms (e.g., flushing, ear itching, dizziness, tremor, tingling, tachycardia, and headache, pain at the injection site) occurred more frequently in the fasting group, which were likely to cause irritability and noncooperation. Encouragingly, the abdomen scan images of 1210 cases were evaluated, and all of them were of adequate diagnostic quality to not require repeated scans. These results suggested that the preparation procedures prior to examinations could be simplified, declining the inconvenience and discomfort of cancer patients.

Very recently, Neeman et al. reported a randomized controlled trial ( NCT03533348) [69], enrolling 2091 hospitalized patients who underwent non-emergency CECT examinations. Among them, 1080 cases were allocated to the fasting group and fasted for at least 4 h, and 1011 cases were allocated to the non-fasting group with unrestricted consumption of liquids and solids. The results showed that no case of aspiration pneumonia was identified within 96 h after examination. There was no statistical difference in the frequency of nausea (6.6% vs 7.6%) and vomiting (2.6% vs 3.0%) between the fasting and non-fasting groups. The subgroup analysis results of 1257 patients receiving oral ICM showed no statistical difference in the frequency of nausea (6.8% vs 8.0%) and vomiting (2.6% vs 3.6%) between the fasting and non-fasting groups. The authors concluded that withholding fasting orders was not associated with increased risk of aspiration pneumonia or increased incidence of emetic complications. The incidence of emetic complications in this study was higher than previous literature [11, 67], but it was consistent with the post-marketing surveillance results of iopromide and one recent report involving LOCM [20, 30]. The prospective observation results of 1112 outpatients showed lower incidence of emetic complications than that in inpatients. It might be attributed to the fact that inpatients were often more susceptible to gastrointestinal adverse events due to analgesia, chemotherapy, advanced cancer and other major diseases [71,72,73].

Current challenges and prospects

This feature Review gives a comprehensive and detailed description of recent advancements of dietary preparation prior to CECT. Based on rigorous and extensive literature review, no single instance of vomiting-associated aspiration pneumonia has been identified due to the undemanding compliance with common preparatory fasting recommendations prior to CECT yet. The probability of clinically important aspiration is negligible. The longstanding traditional concern that unrestricted consumption of liquids and solids may increase the risk of aspiration pneumonia is out of proportion to the actual risk and lacks methodologically acceptable evidence. Allowing free ingestion of liquids and solids prior to CECT will not increase the risk of aspiration pneumonia and the incidence of emetic complications. The available corresponding evidence strongly suggest us to reevaluate and update current preparatory fasting policy for more appropriate management of dietary preparedness. Abolishing unnecessary fasting instructions can simplify the preparation procedures and workflow prior to CECT, improve the radiologic care quality and efficiency, avoid unnecessary delays or cancellations of examinations, and save on health care costs. It can also ensure that patients are in a normal metabolic state, improve patient convenience, tolerance, cooperation, satisfaction, comfort, and well-being, and reduce the excessive fasting related risks (e.g., dehydration and hypoglycemia) in special patient populations.

Nevertheless, this does not mean that patients should undergo all CECT examinations without preparatory fasting. Like all clinical decisions, theoretical risks should be weighed against the pros and cons on an individual basis. Possible scenarios in which patients should be recommended to fast include but are not limited to: (i) Specific types of examinations (e.g., CT virtual gastroscopy, CECT of gastric wall lesions, CT enterography, CT virtual colonoscopy, CT colonography, preoperative three-dimensional anatomical reconstruction and intracavitary virtual exploration), examinations of lesions near intestinal wall (e.g., pancreas, acute abdomen, mesenteric angiography). Given that gastrointestinal emptying is very important to the image quality of the gastrointestinal examinations, to reduce the possibility of interference and confusion between gastrointestinal contents and surrounding lesions, preparatory fasting should be cautiously maintained. In general, we must keep in mind that preparatory fasting is vital to gastrointestinal tract examinations, while in other kind of examinations, preparatory fasting is not always required. In addition, food ingestion can cause the gallbladder to shrink due to the bile release, thus affecting the observation of lesions on the gallbladder wall. (ii) Patients with esophageal diseases or gastric emptying disorders (e.g., gastrointestinal obstruction, achalasia of cardia, hiatal hernia, gastroesophageal reflux, gastroparesis, pyloric stenosis, tracheoesophageal fistula), patients at high risk of aspiration (e.g., impaired consciousness, increased intracranial pressure, impaired swallowing reflex, hyperemesis, severe obesity) [7, 74], patients requiring continuous fasting for clinical needs, and patients under general anesthesia or sedation [7, 70]. (iii) Patients who receive oral contrast media for abdominal examinations usually need to drink about 1 L volume of liquids, so they have poor compliance when they are full and are reluctant to eat or drink beforehand. On the other hand, the fullness of the gastric cavity can affect the delivery time of oral contrast media, therefore, such patients should be fasted.

From the extreme "start fasting after dinner the day before" to the latest preliminary exploration, we have already taken a solid first step and come a long way. Given the extremely low incidence of emetic complications, large sample sizes are essential to ensure the validity and robustness of the conclusions. The majority of current studies on dietary preparation prior to CECT are with small sample sizes and heterogeneous populations and lack randomization and adjustment of potential confounding factors. Although some observational series and indirect evidence suggested that some factors were associated with emetic complications, no cause-and-effect relationship has been established. Current preparatory fasting recommendations are largely consensus driven, and there is still much more refinement to be done. It is urgent to establish a universal and easy-to-popularize dietary preparation standard prior to CECT. In the future, more prospective clinical observations, randomized control trials, large-scale multi-center studies, clinical feasibility data, expert and practitioner opinions, and open forum commentaries are needed to achieve international multidisciplinary consensus. Combined with the category of scientific evidence (e.g., supportive, suggestive, equivocal, insufficient) or opinion evidence (e.g., expert, membership, informal), to elucidate: (i) the causal relationship between the exact time interval, amount, kinds and content of dietary ingestion and the incidence and severity of emetic complications; (ii) the risk factors that affect the incidence and severity of emetic complications induced by different types of ICM; (iii) individualized optimal dietary preparation protocols for special patient populations (e.g., diabetes, tumor radio-chemotherapy, ultra-young patients). For patients with relatively contraindications to dietary ingestion, early risk stratified assessment should be performed based on evidence-based factors (e.g., patient characteristics, comorbidities, and other clinical variables), to evaluate the risk–benefit for specific patients and formulate structured graded dietary management recommendations. (iv) the preventive effect of pre-medication (e.g., gastrointestinal stimulants, gastric acid secretion inhibitors, antacids, antiemetic drugs, anticholinergic drugs, histamine antagonists, sedative drugs) on the incidence and severity of emetic complications. Furthermore, standardized whole process management should be implemented prior to, during and after examination, to further reduce the incidence of emetic complications and minimize the discomfort of patients.

As a concluding remark, we believe that changes in current preparatory fasting policy prior to CECT will make positive and significant implications on clinical practice. We should strive for evidence-based practice, which requires interdisciplinary cooperation of practitioners covering a diverse range of specialties and practice settings. Practitioners and policymakers should raise awareness, continuously improve the medical care quality, strengthen evidence-based communication with the radiology department, and stress the significance of following these instructions. Through health advertisement and education and combination with specific clinical circumstances, explicit, flexible, and personalized dietary preparation plans could be designed. This would ensure both patient safety and good image quality, which is of great importance to achieving optimal radiological nursing practice and patient clinical benefits, and ensuring efficient, reasonable, safe and normative ICM usage.

Availability of data and materials

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.



American Committee of Radiology


Adverse drug reactions


Contrast-enhanced CT


European Society of Urogenital Radiology


High-osmolality contrast media


Iodinated contrast media


Iso-osmolality contrast media


Low-osmolality contrast media


  1. 1.

    Chinese Society of Imaging Technology, China Society for Radiology (2016) CT examination technology expert consensus. Chin J Radiol 50:916–928

    Google Scholar 

  2. 2.

    Lee BY, Ok JJ, Abdelaziz Elsayed AA, Kim Y, Han DH (2012) Preparative fasting for contrast-enhanced CT: reconsideration. Radiology 263:444–450

    PubMed  Google Scholar 

  3. 3.

    American Society of Anesthesiologists C (2011) Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 114:495–511

    Google Scholar 

  4. 4.

    Mendelson CL (1946) Aspiration of stomach contents into lungs during obstetric anesthesia. Am J Obstet Gynecol 52:191–205

    CAS  PubMed  Google Scholar 

  5. 5.

    O’Sullivan G, Scrutton M (2003) NPO during labor. Is there any scientific validation? Anesthesiol Clin North Am 21:87–98

    PubMed  Google Scholar 

  6. 6.

    American Society of Anesthesiologists (2017) Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Task Force on Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration. Anesthesiology 126:376–393

    Google Scholar 

  7. 7.

    Green SM, Leroy PL, Roback MG et al (2020) An international multidisciplinary consensus statement on fasting before procedural sedation in adults and children. Anaesthesia 75:374–385

    CAS  PubMed  Google Scholar 

  8. 8.

    Roy C, Marcus C, Menanteau B et al (1998) Must patients fast before a radiologic examination with injection of an iodinated contrast media? J Radiol 79:892–896

    CAS  PubMed  Google Scholar 

  9. 9.

    Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175:621–628

    CAS  Google Scholar 

  10. 10.

    Han S, Yoon SH, Lee W, Choi YH, Kang DY, Kang HR (2019) Management of adverse reactions to iodinated contrast media for computed tomography in Korean referral hospitals: a survey investigation. Korean J Radiol 20:148–157

    PubMed  Google Scholar 

  11. 11.

    Li X, Liu H, Zhao L et al (2018) The effect of preparative solid food status on the occurrence of nausea, vomiting and aspiration symptoms in enhanced CT examination: prospective observational study. Br J Radiol 91:20180198

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Oowaki K, Saigusa H, Ojiri H, Ariizumi M, Tada S (1994) Relationship between oral food intake and nausea caused by intravenous injection of iodinated contrast material. Nihon Igaku Hoshasen Gakkai Zasshi 54:476–479

    CAS  PubMed  Google Scholar 

  13. 13.

    Geeter PD, Melchior HJ (1994) Iomeprol versus iopromide for intravenous urography. Br J Radiol 67:958–963

    PubMed  Google Scholar 

  14. 14.

    Federle MP, Willis LL, Swanson DP (1998) Ionic versus nonionic contrast media: a prospective study of the effect of rapid bolus injection on nausea and anaphylactoid reactions. J Comput Assist Tomogr 22:341–345

    CAS  PubMed  Google Scholar 

  15. 15.

    Mortelé KJ, Oliva MR, Ondategui S, Ros PR, Silverman SG (2005) Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 184:31–34

    PubMed  Google Scholar 

  16. 16.

    Nagamoto M, Gomi T, Terada H, Terada S, Kohda E (2006) Evaluation of the acute adverse reaction of contrast medium with high and moderate iodine concentration in patients undergoing computed tomography. Radiat Med 24:669–674

    PubMed  Google Scholar 

  17. 17.

    Wendt-Nordahl G, Rotert H, Trojan L et al (2006) Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients. Med Princ Pract 15:358–361

    PubMed  Google Scholar 

  18. 18.

    Vogl TJ, Honold E, Wolf M, Mohajeri H, Hammerstingl R (2006) Safety of iobitridol in the general population and at-risk patients. Eur Radiol 16:1288–1297

    PubMed  Google Scholar 

  19. 19.

    Vijayalakshmi K, Kunadian B, Wright RA et al (2007) A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam (TM)) and iomeprol 350 (Iomeron (R)) in cardiac catheterisation. Eur J Radiol 61:342–350

    PubMed  Google Scholar 

  20. 20.

    Kopp AF, Mortele KJ, Cho YD, Palkowitsch P, Bettmann MA, Claussen CD (2008) Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol 49:902–911

    CAS  PubMed  Google Scholar 

  21. 21.

    Gomi T, Nagamoto M, Hasegawa M et al (2010) Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media? Eur Radiol 20:1631–1635

    PubMed  Google Scholar 

  22. 22.

    Häussler MD (2010) Safety and patient comfort with iodixanol: a postmarketing surveillance study in 9515 patients undergoing diagnostic CT examinations. Acta Radiol 51:924–933

    PubMed  Google Scholar 

  23. 23.

    Maurer M, Heine O, Wolf M, Freyhardt P, Schnapauff D, Hamm B (2011) Safety and tolerability of iobitridol in general and in patients with risk factors: results in more than 160,000 patients. Eur J Radiol 80:357–362

    PubMed  Google Scholar 

  24. 24.

    García M, Aguirre U, Martinez A, Ruiz B, Lertxundi U, Aguirre C (2014) Acute adverse reactions to iopromide vs iomeprol: a retrospective analysis of spontaneous reporting from a radiology department. Br J Radiol 87:20130511

    PubMed  Google Scholar 

  25. 25.

    Pradubpongsa P, Dhana N, Jongjarearnprasert K, Janpanich S, Thongngarm T (2013) Adverse reactions to iodinated contrast media: prevalence, risk factors and outcome-the results of a 3-year period. Asian Pac J Allergy Immunol 31:299–306

    PubMed  Google Scholar 

  26. 26.

    Zhang BC, Hou L, Lv B, Xu YW (2013) Postmarketing Surveillance Study with Iodixanol in 20,185 Chinese Patients from Routine Clinical Practices. Br J Radiol 87:20130325

    PubMed  Google Scholar 

  27. 27.

    Müller FH (2014) Post-marketing surveillance of the safety profile of iodixanol in the outpatient CT setting: a prospective, multicenter, observational study of patient risk factors, adverse reactions and preventive measures in 9953 patients. Rofo 186:1028–1034

    PubMed  Google Scholar 

  28. 28.

    Palkowitsch PK, Bostelmann S, Lengsfeld P (2014) Safety and tolerability of iopromide intravascular use: a pooled analysis of three non-interventional studies in 132,012 patients. Acta Radiol 55:707–714

    PubMed  Google Scholar 

  29. 29.

    Li X, Chen J, Zhang L et al (2015) Clinical observation of the adverse drug reactions caused by non-ionic iodinated contrast media: results from 109,255 cases who underwent enhanced CT examination in Chongqing. China Br J Radiol 88:20140491

    CAS  PubMed  Google Scholar 

  30. 30.

    Zhang B, Dong Y, Liang L et al (2016) The incidence, classification, and management of acute adverse reactions to the low-osmolar iodinated contrast media Isovue and ultravist in contrast-enhanced computed tomography scanning. Medicine (Baltimore) 95:e3170

    Google Scholar 

  31. 31.

    Kim YS, Yoon SH, Choi YH, Chang MP, Jin MG (2018) Nausea and vomiting after exposure to non-ionic contrast media: incidence and risk factors focusing on preparatory fasting. Br J Radiol 91:20180107

    PubMed  PubMed Central  Google Scholar 

  32. 32.

    Ha JY, Choi YH, Cho YJ et al (2020) Incidence and risk factors of nausea and vomiting after exposure to low-osmolality iodinated contrast media in children: a focus on preparative fasting. Korean J Radiol 21:1178–1186

    PubMed  PubMed Central  Google Scholar 

  33. 33.

    European Society of Urogenital Radiology. (2018) ESUR Guidelines on Contrast Agents. Version 10.0.

  34. 34.

    ACR Committee on Drugs and Contrast Media (2021) ACR Manual on Contrast Media. Available at:

  35. 35.

    Welliver M (2013) Nausea and vomiting: mechanisms and treatment overview. Gastroenterol Nurs 36:378–380

    PubMed  Google Scholar 

  36. 36.

    Gupta K, Walton R, Kataria SP (2021) Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun 26:100278.

    Article  PubMed  Google Scholar 

  37. 37.

    Sherani F, Boston C, Mba N (2019) Latest update on prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients. Curr Oncol Rep 21:89

    PubMed  PubMed Central  Google Scholar 

  38. 38.

    Marik PE (2001) Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344:665–671

    CAS  PubMed  Google Scholar 

  39. 39.

    Roberts RB, Shirley MA (1980) Antacid therapy in obstetrics. Anesthesiology 53:83

    CAS  PubMed  Google Scholar 

  40. 40.

    Fawcett WJ, Thomas M (2019) Pre-operative fasting in adults and children: clinical practice and guidelines. Anaesthesia 74:83–88

    CAS  PubMed  Google Scholar 

  41. 41.

    Sutherland AD, Maltby JR, Sale JP, Reid C (1987) The effect of preoperative oral fluid and ranitidine on gastric fluid volume and pH. Can J Anaesth 34:117–121

    CAS  PubMed  Google Scholar 

  42. 42.

    American Society of Anesthesiologists (2017) Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures. Anesthesiology 126:376–393

    Google Scholar 

  43. 43.

    Yu JM (2015) Practice of medical imaging technology. People's Medical Publishing House(PMPH): 523–657

  44. 44.

    Berther R, Patak MA, Eckhardt B, Erturk SM, Zollikofer CL (2008) Comparison of neutral oral contrast versus positive oral contrast medium in abdominal multidetector CT. Eur Radiol 18:1902–1909

    PubMed  Google Scholar 

  45. 45.

    Hashemi J, Davoudi Y, Taghavi M, Pezeshki Rad M, Moghadam AM (2014) Improvement of distension and mural visualization of bowel loops using neutral oral contrasts in abdominal computed tomography. World J Radiol 6:907–912

    PubMed  PubMed Central  Google Scholar 

  46. 46.

    Lee IJ, Lee JM, Kim SH et al (2009) Helical CT evaluation of the preoperative staging of gastric cancer in the remnant stomach. AJR Am J Roentgenol 192:902–908

    PubMed  Google Scholar 

  47. 47.

    Chinese Society of Radiology (2013) Iodine contrast agents application guideline. Chin J Radiol 47:869–872

    Google Scholar 

  48. 48.

    Ellis JH, Cohan RH (2009) Reducing the risk of contrast-induced nephropathy: a perspective on the controversies. AJR Am J Roentgenol 192:1544–1549

    PubMed  Google Scholar 

  49. 49.

    Kwatra NS, Shalaby-Rana E, Andrich MP et al (2020) Gastric emptying of milk in infants and children up to 5 years of age: normative data and influencing factors. Pediatr Radiol 50:689–697

    PubMed  Google Scholar 

  50. 50.

    Agrawal D (2018) Nil per Os before procedures-time to reevaluate the practice. JAMA Intern Med 178:434–435

    PubMed  Google Scholar 

  51. 51.

    Wickerham AL, Schultz EJ, Lewine EB (2017) Nil per Os orders for imaging: a teachable moment. JAMA Intern Med 177:1670–1671

    PubMed  Google Scholar 

  52. 52.

    Sorita A, Thongprayoon C, Ahmed A et al (2015) Frequency and appropriateness of fasting orders in the hospital. Mayo Clin Proc 90:1225–1232

    PubMed  Google Scholar 

  53. 53.

    Singh S, Reddicliffe N, Parker DA (2008) Patient preparation for intravenous urography: are we practising evidence-based medicine? Clin Radiol 63:170–173

    CAS  PubMed  Google Scholar 

  54. 54.

    Hamid T, Aleem Q, Lau Y et al (2014) Pre-procedural fasting for coronary interventions: is it time to change practice? Heart 100:658–661

    PubMed  Google Scholar 

  55. 55.

    Clauss MW (1999) What is the place of fasting and dehydration before contrast media administration? In: Dawson P (ed) Contrast media in practice: question and answers, 2nd edn. Springer, New York, pp 118–119

    Google Scholar 

  56. 56.

    Correa-Arruda WS, Vaez IDA, Aguilar-Nascimento JE, Dock-Nascimento DB (2019) Effects of overnight fasting on handgrip strength in inpatients. Einstein (Sao Paulo) 17:eAO418.

    Article  Google Scholar 

  57. 57.

    Carey SK, Conchin S, Bloomfield-Stone S (2015) A qualitative study into the impact of fasting within a large tertiary hospital in Australia–the patients’ perspective. J Clin Nurs 24:1946–1954

    PubMed  Google Scholar 

  58. 58.

    Nygren J, Thorell A, Ljungqvist O (2007) Are there any benefits from minimizing fasting and optimization of nutrition and fluid management for patients undergoing day surgery? Curr Opin Anaesthesiol 20:540–544

    PubMed  Google Scholar 

  59. 59.

    Engelhardt T, Wilson G, Horne L, Weiss M, Schmitz A (2011) Are you hungry? Are you thirsty?–fasting times in elective outpatient pediatric patients. Paediatr Anaesth 21:964–968

    PubMed  Google Scholar 

  60. 60.

    Frykholm P, Schindler E, Sumpelmann R, Walker R, Weiss M (2018) Preoperative fasting in children: review of existing guidelines and recent developments. Br J Anaesth 120:469–474

    CAS  PubMed  Google Scholar 

  61. 61.

    Brady M, Kinn S, Ness V, O’Rourke K, Randhawa N, Stuart P (2009) Preoperative fasting for preventing perioperative complications in children. Cochrane Database Syst Rev.

    Article  PubMed  Google Scholar 

  62. 62.

    Dennhardt N, Beck C, Huber D et al (2016) Optimized preoperative fasting times decrease ketone body concentration and stabilize mean arterial blood pressure during induction of anesthesia in children younger than 36 months: a prospective observational cohort study. Pediatr Anesth 26:838–843

    Google Scholar 

  63. 63.

    Smith I, Kranke P, Murat I et al (2011) Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 28:556–569

    PubMed  Google Scholar 

  64. 64.

    Wagner HJ, Evers JP, Hoppe M, Klose KJ (1997) Must the patient fast before intravascular injection of a non-ionic contrast medium? Results of a controlled study. Rofo 166:370–375

    CAS  PubMed  Google Scholar 

  65. 65.

    Park JH, Rhee JE, Kim KS, Shin JH (2008) Is the six-hour fasting before abdominal computed tomography necessary to prevent gastrointestinal adverse events in patients with abdominal pain? J Korean Soc Emerg Med 19(3):333–338

    Google Scholar 

  66. 66.

    Li X, Liu H, Zhao L et al (2017) Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors. Br J Radiol 90:20160729

    PubMed  PubMed Central  Google Scholar 

  67. 67.

    Barbosa P, Bitencourt AGV, Tyng CJ et al (2018) JOURNAL CLUB: preparative fasting for contrast-enhanced CT in a cancer center: a new approach. AJR Am J Roentgenol 210:941–947

    PubMed  Google Scholar 

  68. 68.

    Tsushima Y, Seki Y, Nakajima T et al (2020) The effect of abolishing instructions to fast prior to contrast-enhanced CT on the incidence of acute adverse reactions. Insights Imaging 11:113.

    Article  PubMed  PubMed Central  Google Scholar 

  69. 69.

    Neeman Z, Abu Ata M, Touma E et al (2021) Is fasting still necessary prior to contrast-enhanced computed tomography? A randomized clinical study. Eur Radiol 31:1451–1459

    PubMed  Google Scholar 

  70. 70.

    Coté CJ, Wilson S (2019) Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures. Pediatr Dent 41:259–260

    PubMed  Google Scholar 

  71. 71.

    Molassiotis A, Lee PH, Burke TA et al (2016) Anticipatory nausea, risk factors, and its impact on chemotherapy-induced nausea and vomiting: results from the pan european emesis registry study. J Pain Symptom Manag 51:987–993

    Google Scholar 

  72. 72.

    Molassiotis A, Russell W, Hughes J et al (2014) The effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: a randomized controlled trial. J Pain Symptom Manag 47:12–25

    Google Scholar 

  73. 73.

    Rapoport BL (2017) Delayed chemotherapy-induced nausea and vomiting: pathogenesis, incidence, and current management. Front Pharmacol 8:19.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  74. 74.

    Sakai T, Planinsic RM, Quinlan JJ, Handley LJ, Kim TY, Hilmi IA (2006) The incidence and outcome of perioperative pulmonary aspiration in a university hospital: a 4-year retrospective analysis. Anesth Analg 103:941–947

    PubMed  Google Scholar 

Download references


The authors would thank Mr. Zhongcan Li for English language proofreading & polishing.


This work was supported by the National Natural Science Foundation of China (NSFC, 81901872, 82001889), the Fund of Chongqing 2019 Science and Technology Joint Medical Research Project (2019ZDXM049) and Chongqing Clinical Research Center for Imaging and Nuclear Medicine (CSTC2015YFPT-gcjsyjzx0175).

Author information




H.L. and Y.L. contributed equally to this work. Guarantors of integrity of entire study, L.Z., X.L., W.G.Z.; study concepts/study design, X.L., W.G.Z.; manuscript drafting for important intellectual content, H.L., Y.L., L.Z.; approval of final version of submitted manuscript, all authors; agrees to ensure any questions related to the work are appropriately resolved, all authors; literature search, H.L., Y.L., L.Z.; and manuscript editing, X.L., W.G.Z. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Xue Li or Weiguo Zhang.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, H., Liu, Y., Zhao, L. et al. Preprocedural fasting for contrast-enhanced CT: when experience meets evidence. Insights Imaging 12, 180 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Preparatory fasting
  • Contrast-enhanced CT
  • Nausea
  • Vomiting
  • Aspiration pneumonia